Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
Veteran Life Sciences Executives Bring Extensive Public Company Operating Experience to Leadership Team CINCINNATI, Oct….
News
Carmot Therapeutics Announces that Preliminary Phase 1 Results Support Once-daily Oral Dosing for its Obesity and Type 2 Diabetes Candidate CT-996
BERKELEY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — Carmot Therapeutics, Inc. (Carmot), a clinical-stage biotechnology…
Carmot Therapeutics Announces that Preliminary Phase 1 Results Support Once-daily Oral Dosing for its Obesity and Type 2 Diabetes Candidate CT-996
BERKELEY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — Carmot Therapeutics, Inc. (Carmot), a clinical-stage biotechnology…
Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
American Journal of Respiratory and Critical Care Medicine Publishes Full, Positive Results of Apnimed’s MARIPOSA Study on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea
— Phase 3 Clinical Trials for AD109 Currently Enrolling Patients in the U.S. CAMBRIDGE, Mass.,…
Helsinn closes financing agreement with BancaStato to support business objectives and growth
Helsinn closes financing agreement with BancaStato to support business objectives and growth New funding secured…
American Journal of Respiratory and Critical Care Medicine Publishes Full, Positive Results of Apnimed’s MARIPOSA Study on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea
— Phase 3 Clinical Trials for AD109 Currently Enrolling Patients in the U.S. CAMBRIDGE, Mass.,…
Helsinn closes financing agreement with BancaStato to support business objectives and growth
Helsinn closes financing agreement with BancaStato to support business objectives and growth New funding secured…
Cerevance to Participate at the 3rd Annual Needham Biotech Private Company Forum
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Cerevance to Participate at the 3rd Annual Needham Biotech Private Company Forum
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Aruna Bio to Participate in the BIO Investor Forum in October 2023
BOSTON and ATHENS, Ga., Oct. 10, 2023 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a leader…
Aruna Bio to Participate in the BIO Investor Forum in October 2023
BOSTON and ATHENS, Ga., Oct. 10, 2023 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a leader…
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache…
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache…
Rhythm Pharmaceuticals Announces Six Abstracts to be Presented at The Obesity Society’s Annual Meeting at ObesityWeek ®
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Rhythm Pharmaceuticals Announces Six Abstracts to be Presented at The Obesity Society’s Annual Meeting at ObesityWeek ®
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced,…
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced,…
Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…